Trial Profile
Comparison of efficacy of 4 mg and 8 mg doses of doxazosin in patients with benign prostatic hyperplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Doxazosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 03 Dec 2015 New trial record